FDA.reportPublic FDA data

abaloparatide 80 MCG per 0.04 ML Pen Injector

RxCUI
1921075
RxNorm name
abaloparatide 80 MCG per 0.04 ML Pen Injector
Display name
abaloparatide 80 MCG per 0.04 ML Pen Injector
Full name
abaloparatide 80 MCG per 0.04 ML Pen Injector
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TymlosABALOPARATIDERadius Health, Inc.712143d9-e21e-4013-bb3b-3426a21060a82025-04-04Warnings, Adverse reactionsExact identifier
rxcui: 1921075

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
712143d9-e21e-4013-bb3b-3426a21060a8abaloparatide 80 MCG per 0.04 ML Pen InjectorSY18These highlights do not include all the information needed to use TYMLOS safely and effectively. See full prescribing information for TYMLOS. TYMLOS ® (abaloparatide) injection, for subcutaneous use Initial U.S. Approval: 201720250404
712143d9-e21e-4013-bb3b-3426a21060a8abaloparatide 3120 MCG per 1.56 ML Pen InjectorSY18These highlights do not include all the information needed to use TYMLOS safely and effectively. See full prescribing information for TYMLOS. TYMLOS ® (abaloparatide) injection, for subcutaneous use Initial U.S. Approval: 201720250404
712143d9-e21e-4013-bb3b-3426a21060a8abaloparatide 2000 MCG/ML per 1.56 ML Pen InjectorSY18These highlights do not include all the information needed to use TYMLOS safely and effectively. See full prescribing information for TYMLOS. TYMLOS ® (abaloparatide) injection, for subcutaneous use Initial U.S. Approval: 201720250404
712143d9-e21e-4013-bb3b-3426a21060a81.56 ML abaloparatide 2 MG/ML Pen InjectorSCD18These highlights do not include all the information needed to use TYMLOS safely and effectively. See full prescribing information for TYMLOS. TYMLOS ® (abaloparatide) injection, for subcutaneous use Initial U.S. Approval: 201720250404
712143d9-e21e-4013-bb3b-3426a21060a8abaloparatide 3120 MCG in 1.56 ML Pen InjectorPSN18These highlights do not include all the information needed to use TYMLOS safely and effectively. See full prescribing information for TYMLOS. TYMLOS ® (abaloparatide) injection, for subcutaneous use Initial U.S. Approval: 201720250404